Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease
暂无分享,去创建一个
E. Masliah | J. Morris | D. McKeel | D. McKeel | R. DeTeresa | M. Mallory | L. Hansen | M. Alford | R. DeTeresa | E. Masliah | J. Morris | M. Alford | L.A. Hansen | M. Mallory | D.W. McKeel | J.C. Morris
[1] L. Lue,et al. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .
[2] L. Lue,et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.
[3] L. Thal,et al. Clinical Dementia Rating training and reliability in multicenter studies , 1997, Neurology.
[4] D. Salmon,et al. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer' s disease , 1996, Brain Research.
[5] K. Blennow,et al. Synaptotagmin, a synaptic vesicle protein, is present in human cerebrospinal fluid: a new biochemical marker for synaptic pathology in Alzheimer disease? , 1996, Molecular and chemical neuropathology.
[6] Brian J Cummings,et al. Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity , 1995, The Lancet.
[7] P. De Camilli,et al. A radioimmunoassay to monitor synaptic activity in hippocampal neurons in vitro. , 1995, European journal of cell biology.
[8] E. Masliah,et al. Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.
[9] K. Jellinger,et al. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients , 1993, Neuroscience Letters.
[10] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[11] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.